Informa Life Sciences will hold its 7th annual "Global Generics Strategy Summit" conference in Barcelona, Spain, March 4-5, 2008. The conference "represents the largest gathering of Generics leaders from across the globe and will explore new and emerging strategies and regulations that must be followed to remain competitive in this cut-throat industry."
The conference features keynote presentations from executives of Ratiopharm Group, Ranbaxy, Barr Labs, and Biogenerics. In addition, several talks are offered on each of the following subjects: legal and regulatory issues; biosimilars; pricing and reimbursement; and business development.
Moreover, four pre- and post-conference workshops will be offered: on March 3rd, "Merger and Acquisition Within the Generics Marketplace" and "Evaluation of Existing and Development of New Strategic Business Models to Stay Ahead in the Generics Sector"; and on March 6th, "Criteria for Selecting Member States to Include in a Decentralised Procedure Application" and "Implementing Fast-Track Development and Launch Strategies and Being the First Generic to Market."
For more information or to register, please visit the conference website.

Leave a comment